Patent · US Expired

Treatment of inflammation and allergy

US5290815A · kind A · utility

32Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 25, 1991
Grant dateMar 1, 1994
Priority date
Expiry dateNov 25, 2011

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/135
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a new medical use for the phenethanolamine compound 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol and physiologically acceptable salts and solvates thereof in the treatment of inflammation, allergy and allergic reaction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.